Beijing 302 Hospital
Clinical trials sponsored by Beijing 302 Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a cancer drug help cure hepatitis b? new trial launches Results expected Oct 2026 (estimated)
- Can a daily pill help breast cancer that outsmarts two antibody drugs? Results expected Dec 2026 (estimated)
- Shock therapy? no, just a gentle tingle to ease ERCP sedation risks Results expected Aug 2027 (estimated)
-
Can a daily pill help breast cancer that outsmarts two antibody drugs?
Disease control OngoingResearchers are reviewing medical records to see how well pyrotinib works and how safe it is in people with HER2-positive advanced breast cancer whose disease worsened after treatment with trastuzumab and pertuzumab. The study includes about 200 patients in China who received pyr…
Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a cancer drug help cure hepatitis b? new trial launches
Disease control OngoingThis pilot study tests whether adding a PD-1 antibody (sintilimab) and pegylated interferon to standard antiviral therapy can help people with chronic hepatitis B lose the hepatitis B surface antigen (HBsAg), a key step toward a functional cure. The trial will enroll 45 adults wh…
Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC